Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Regulatory News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Rule and guidance for emergency face masks: FDA final 1rule down-classifies filtering facepiece respirators for use in public health emergencies to Class II. The rule also requires that the devices be certified by the National Institute for Occupational Safety and Health and that manufacturers address additional issues discussed in a July 3 2guidance. The device, a disposable half-facepiece non-powered air-purifying particulate respirator, is intended to cover the nose and mouth to reduce exposure to pathogenic biological airborne particulates, for instance during a flu pandemic. FDA's guidance, "Class II Special Controls Guidance Document: Filtering Facepiece Respirator for Use by the General Public in Public Health Medical Emergencies," details how manufacturers can assure good filtration and breathability, proper fit and use, and gentleness to the wearer's skin. 3M, maker of the recently cleared 8612F and 8670F facepiece respirators, requested the Class II designation for the new device type last October (3"The Gray Sheet" May 14, 2007, p. 18)...

Related Content




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts